Castle Biosciences (CSTL)
(Real Time Quote from BATS)
$29.00 USD
-0.25 (-0.86%)
Updated Sep 25, 2024 10:06 AM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Castle Biosciences, Inc. (CSTL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$35.00 | $45.00 | $28.00 | 19.66% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Castle Biosciences, Inc. comes to $35.00. The forecasts range from a low of $28.00 to a high of $45.00. The average price target represents an increase of 19.66% from the last closing price of $29.25.
Analyst Price Targets (9 )
Broker Rating
Castle Biosciences, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on nine recommendations.
Of the nine recommendations deriving the current ABR, nine are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 9 | 9 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/24/2024 | BTIG | Mark Massaro | Strong Buy | Strong Buy |
9/5/2024 | Guggenheim Securities | Subbu Nambi | Strong Buy | Strong Buy |
9/4/2024 | Canaccord Genuity | Kyle Mikson | Strong Buy | Strong Buy |
8/7/2024 | Scotiabank | Sung-Ji Nam | Strong Buy | Strong Buy |
8/6/2024 | Lake Street Capital Markets | Thomas Flaten | Strong Buy | Strong Buy |
8/6/2024 | Stephens | Mason Carrico | Strong Buy | Strong Buy |
8/6/2024 | Robert W. Baird & Co. | Catherine W Schulte | Strong Buy | Strong Buy |
7/30/2024 | SVB Securities | Puneet Souda | Strong Buy | Strong Buy |
3/1/2024 | KeyBanc Capital Markets | Paul Knight | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 9 |
Average Target Price | $35.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | -0.08 |
CSTL FAQs
Castle Biosciences, Inc. (CSTL) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 9 brokerage firms.
The average price target for Castle Biosciences, Inc. (CSTL) is $35.00. The current on short-term price targets is based on 2 reports.
The forecasts for Castle Biosciences, Inc. (CSTL) range from a low of $28 to a high of $45. The average price target represents a increase of $19.66 from the last closing price of $29.25.
The current UPSIDE for Castle Biosciences, Inc. (CSTL) is 19.66%
Based on short-term price targets offered by nine analysts, the average price target for Castle Biosciences, Inc. comes to $35.00. The forecasts range from a low of $28.00 to a high of $45.00. The average price target represents an increase of 19.66% from the last closing price of $29.25.